On August 24, 2021, the U.S. Preventive Services Task Force (USPSTF) revised their recommendations for type 2 diabetes and pre-diabetes screening. The revision includes a recommendation that screening of all overweight and obese adults should begin at age 35 rather than age 40, per their previous recommendation in 2015.
Asthma is one of the most common conditions we see in primary care and can result in significant morbidity and mortality if not diagnosed and managed optimally. The National Heart, Lung, and Blood Institute (NHLBI) has sponsored a consensus panel to develop clinical practice guidelines for child and adult asthma since 1989. The guidelines were updated at the end of 2020 for the first time in over a decade.
Each year the American Diabetes Association (ADA) updates its evidence-based clinical practice guidelines, Standards of Medical Care in Diabetes. This article reviews the annual update with emphasis on those changes most relevant to primary care practice.
Dr. Charles Sneiderman reviews the clinical practice guidelines for preventive services recommended for primary care providers and indicates that the guidelines of the Federal Department of Health and Human Services are the standard for reimbursable preventive care.
This activity will provide the attendee with the latest up-to-date information and state-of-the-art management strategies using oral antiplatelet drugs for Acute Coronary Syndrome patients based on the 2013 ACC/AHA Guidelines.
This educational activity will discuss appropriate screening and assessment for glycemia and associated comorbidities and review safety, efficacy, mechanisms of action, and place for non-insulin therapies within the treatment algorithm.
This activity was developed from the live Best Practices in Primary Care™ program held in Chicago, Illinois on June 21, 2014. The expert faculty will discuss the strategies pertaining to appropriate initiation and intensification of insulin therapy.
Hypogonadism is an underdiagnosed syndrome with links to age, obesity, type 2 diabetes mellitus (T2DM), and metabolic syndromes. This activity will help clinicians with appropriate screening, diagnosis, and available testosterone supplemental therapies.
The ACC/AHA guidelines has 9 recommendations for hypertension. Dr. Charles Sneiderman reviews the new guidelines published in 2014 by the National Institutes of Health eighth Joint National Committee (JNC8).